MEK inhibitors suppress β-amyloid production by altering the level of a β-C-terminal fragment of amyloid precursor protein in neuronal cells

被引:9
作者
Araki, Wataru [1 ]
Kametani, Fuyuki [2 ]
Oda, Akiko [1 ,3 ]
Tamaoka, Akira [3 ]
机构
[1] Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Kodaira, Tokyo 1878502, Japan
[2] Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Setagaya Ku, Tokyo 1568585, Japan
[3] Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 3058575, Japan
关键词
Alzheimer's disease; Amyloid precursor protein; beta-Amyloid; MEK inhibitor; Neuroblastoma; Proteasome; ALZHEIMERS-DISEASE; DEPENDENT MECHANISM; BRAIN; PEPTIDE; KINASE; PS2;
D O I
10.1016/j.febslet.2010.06.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
beta-Amyloid peptide (A beta) is generated via sequential proteolysis of amyloid precursor protein (APP) by beta- and gamma-secretases. Cell-based screening experiments disclosed that the MEK (MAP kinase kinase) inhibitors, U0126 and PD184352, suppress A beta secretion from human neuronal SH-SY5Y cells expressing Swedish mutant APP. These inhibitors did not affect the cellular levels of APP but significantly reduced those of the APP beta-C-terminal fragment (beta-CTF). Additionally, beta-CTF levels were markedly reduced by these inhibitors in cells expressing the fragment in a gamma-secretase-independent and proteasome-dependent manner. Our results suggest that MEK inhibitors reduce A beta generation via secretase-independent alteration of beta-CTF levels. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3410 / 3414
页数:5
相关论文
共 15 条
[1]
Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons [J].
Araki, W ;
Yuasa, K ;
Takeda, S ;
Takeda, K ;
Shirotani, K ;
Takahashi, K ;
Tabira, T .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (06) :1161-1168
[2]
IGF-1 promotes β-amyloid production by a secretase-independent mechanism [J].
Araki, Wataru ;
Kume, Hideaki ;
Oda, Akiko ;
Tamaoka, Akira ;
Kametani, Fuyuki .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (01) :111-114
[3]
Targeting protein kinases in central nervous system disorders [J].
Chico, Laura K. ;
Van Eldik, Linda J. ;
Watterson, D. Martin .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (11) :892-909
[4]
β-Secretase inhibition for the treatment of Alzheimer's disease -: promise and challenge [J].
Citron, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (02) :92-97
[5]
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain [J].
Dovey, HF ;
John, V ;
Anderson, JP ;
Chen, LZ ;
Andrieu, PD ;
Fang, LY ;
Freedman, SB ;
Folmer, B ;
Goldbach, E ;
Holsztynska, EJ ;
Hu, KL ;
Johnson-Wood, KL ;
Kennedy, SL ;
Kholedenko, D ;
Knops, JE ;
Latimer, LH ;
Lee, M ;
Liao, Z ;
Lieberburg, IM ;
Motter, RN ;
Mutter, LC ;
Nietz, J ;
Quinn, KP ;
Sacchi, KL ;
Seubert, PA ;
Shopp, GM ;
Thorsett, ED ;
Tung, JS ;
Wu, J ;
Yang, S ;
Yin, CT ;
Schenk, DB ;
May, PC ;
Altstiel, LD ;
Bender, MH ;
Boggs, LN ;
Britton, TC ;
Clemens, JC ;
Czilli, DL ;
Dieckman-McGinty, DK ;
Droste, JJ ;
Fuson, KS ;
Gitter, BD ;
Hyslop, PA ;
Johnstone, EM ;
Li, WY ;
Little, SP ;
Mabry, TE ;
Miller, FD ;
Ni, B .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :173-181
[6]
Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632
[7]
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356
[8]
SECRETORY FORM OF ALZHEIMER AMYLOID PRECURSOR PROTEIN-695 IN HUMAN BRAIN LACKS BETA-A4 AMYLOID IMMUNOREACTIVITY [J].
KAMETANI, F ;
TANAKA, K ;
ISHII, T ;
IKEDA, S ;
KENNEDY, HE ;
ALLSOP, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (02) :392-398
[9]
The Two-Hydrophobic Domain Tertiary Structure of Reticulon Proteins Is Critical for Modulation of β-Secretase BACE1 [J].
Kume, Hideaki ;
Murayama, Kiyoko S. ;
Araki, Wataru .
JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (13) :2963-2972
[10]
Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia [J].
Namura, S ;
Iihara, K ;
Takami, S ;
Nagata, I ;
Kikuchi, H ;
Matsushita, K ;
Moskowitz, MA ;
Bonventre, JV ;
Alessandrini, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11569-11574